France
# |
Name |
EBIT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
17.86%
|
Dec. 31, 2023 | USD 107.78 | 1.15% |
|
France |
|
2 |
14.70%
|
Dec. 31, 2023 | USD 75.53 | 2.94% |
|
France |
|
3 |
10.30%
|
Dec. 31, 2023 | USD 3.53 | -0.92% |
|
France |
|
4 |
7.88%
|
Dec. 31, 2023 | USD 26.53 | -0.92% |
|
France |
|
5 |
-24.41%
|
Dec. 31, 2023 | USD 2.01 | -0.78% |
|
France |
|
6 |
-48.99%
|
Dec. 31, 2023 | USD 3.21 | 17.34% |
|
France |
|
7 |
-54.30%
|
Dec. 31, 2023 | USD 2.58 | -11.21% |
|
France |
|
8 |
-105.12%
|
Dec. 31, 2023 | USD 3.47 | -1.52% |
|
France |
|
9 |
-151.00%
|
Dec. 31, 2023 | USD 1.39 | 1.77% |
|
France |
|
10 |
-170.22%
|
March 31, 2024 | USD 16.83 | 1.50% |
|
France |
|
11 |
-240.83%
|
Dec. 31, 2023 | USD 0.65 | 1.19% |
|
France |
|
12 |
-527.02%
|
Dec. 31, 2023 | USD 4.22 | -0.94% |
|
France |
|
13 |
-598.32%
|
Dec. 31, 2023 | USD 2.43 | 0.68% |
|
France |
|
14 |
-923.35%
|
Dec. 31, 2023 | USD 5.64 | -2.27% |
|
France |
|
15 |
-944.14%
|
Dec. 31, 2023 | USD 6.63 | -0.22% |
|
France |
|
16 |
-1,058.87%
|
Dec. 31, 2023 | USD 1.64 | 4.90% |
|
France |
|
17 |
-2,897.94%
|
Dec. 31, 2023 | USD 5.91 | -2.66% |
|
France |
The Vaccines company in France with the highest EBIT Margin is Sanofi (Paris Stock Exchange: SAN.PA) at 17.86%.
The Vaccines company in France with the lowest EBIT Margin is ABIVAX SA (Paris Stock Exchange: ABVX.PA) at -2,897.94%.
The top 10 Vaccines companies in France by EBIT Margin are Sanofi, Vetoquinol SA, genOway SA, Eurobio Scientific SA, Innate Pharma S.A., Valneva SE, Aelis Farma SA, Nanobiotix S.A., Valbiotis SA and MedinCell S.A..
The bottom 10 Vaccines companies in France by EBIT Margin are ABIVAX SA, AB Science S.A., OSE Immunotherapeutics SA, Adocia SA, Inventiva S.A., DBV Technologies S.A., Novacyt S.A., MedinCell S.A., Valbiotis SA and Nanobiotix S.A..